135 related articles for article (PubMed ID: 21268059)
1. Control of RUNX3 by histone methyltransferases.
Lee YM
J Cell Biochem; 2011 Feb; 112(2):394-400. PubMed ID: 21268059
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
3. RUNX3: a new player in myeloid gene expression and immune response.
Puig-Kröger A; Corbí A
J Cell Biochem; 2006 Jul; 98(4):744-56. PubMed ID: 16598764
[TBL] [Abstract][Full Text] [Related]
4. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
[TBL] [Abstract][Full Text] [Related]
5. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
8. The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression.
Puig-Kröger A; Aguilera-Montilla N; Martínez-Nuñez R; Domínguez-Soto A; Sánchez-Cabo F; Martín-Gayo E; Zaballos A; Toribio ML; Groner Y; Ito Y; Dopazo A; Corcuera MT; Alonso Martín MJ; Vega MA; Corbí AL
Immunobiology; 2010; 215(9-10):812-20. PubMed ID: 20615577
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
13. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation.
Soung do Y; Dong Y; Wang Y; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2007 Aug; 22(8):1260-70. PubMed ID: 17488194
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of RUNX3 in head and neck cancer.
Kudo Y; Tsunematsu T; Takata T
J Cell Biochem; 2011 Feb; 112(2):387-93. PubMed ID: 21268058
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
[TBL] [Abstract][Full Text] [Related]
19. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
Chuang LS; Ito Y
Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
[TBL] [Abstract][Full Text] [Related]
20. Runx3 negatively regulates Osterix expression in dental pulp cells.
Zheng L; Iohara K; Ishikawa M; Into T; Takano-Yamamoto T; Matsushita K; Nakashima M
Biochem J; 2007 Jul; 405(1):69-75. PubMed ID: 17352693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]